Industry-academia collaborations, seminar series by Cancer Research KI

Cancer Research KI launches a new seminar series on Industrial Collaboration. We will discuss topics such as legal issues, commission, collaboration but also there will be a chance to get inspired by researchers, who have already collaborated with the industry.

Industry

Programme for the seminar on the 12th of October, 2022

Registration is open now

Welcome to the hybrid seminar organised by Cancer Research KI. Swedish Intellectual Property Office (PRV) will give a talk about about how to create value around Intellectual Property (IP) as a researcher. Hans-Gustaf Ljunggren will  present a couple of examples of IP. There will be time to discuss and ask questions during the afternoon. Please join either via zoom or in real life where fika will be served before the meeting. Details obtained after the registration.

13.00 - 13.45 "How to create value around IP as a researcher" Carl Hamsten  

13.45 - 14.00 Examples by a researcher, Hans-Gustaf Ljunggren

14.00 -14.15 KI perspective, Richard Cowburn (how to deal with confidentiality, teachers perspective) 

14.15 - 15.00 Panel discussion and answers to questions

Previous seminars

Programme for the seminar on the 19th of May, 2022, KI/Merck: existing and potential collaborations 

During this seminar, you will learn how Merck is looking to expand their ongoing collaboration with KI in the areas of oncology and immuno-oncology.  An ongoing project will also be presented. There will be time to discuss and ask questions during the afternoon.

13.45-14.00 : Coffee and networking

14.00-14.10 : Welcome and Introduction Simon Ekman (Cancer Research KI) and Sven Pötzsch (Merck Healthcare KGaA)

14.10- 14.30 : Richard Cowburn (KI) KI perspectives on Industry/Academia Partnerships the research area of Oncology 

14.30- 14.50 : Kahina Lang (Merck Healthcare KGaA)  Strategic Innovation at Merck: Motivation and Mission

14.50- 14.55: Short break

14.55- 15.15 : Eike-Benjamin Braune (KI)  Modulation of NOTCH Signaling as a new treatment option for solid tumors

15.15- 15.35 : Felix Geist (Merck Healthcare KGaA) Identification of a NOTCH transcriptomic signature for basal like breast cancer

15.35-15.55: Simon Ekman (Cancer Research KI), Richard Cowburn (KI) and Sven Pötzsch (Merck Healthcare KGaA) Open discussion

15.55: Closing remarks Simon Ekman

Programme for the seminar on January 20th, 2022

13.00 Welcoming words: Simon Ekman Leader of the Industrial collaboration working group CRKI

13.10 Why collaborate with industry? High-level examples of industrial relations KI have established within oncology: Richard Cowburn

14.00 Short break

14.10 KI processes and ways of working with industry: Richard Cowburn and External Engagement office

15.00 Conclusions and final remarks

Please register by sending an e-mail to cancerresearchKI@ki.se by Monday 17th of January